A way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The scientific efforts led by Salvemini, who is professor of pharmacological and physiological sciences at SLU, demonstrated that turning on a receptor in the brain and spinal cord counteracts chronic nerve pain in male and female rodents. Activating the A3 receptor – either by its native chemical stimulator, the small molecule adenosine, or by powerful synthetic small molecule drugs invented at the NIH – prevents or reverses pain that develops slowly from nerve damage without causing analgesic tolerance or intrinsic reward (unlike opioids).
An Unmet Medical Need
Pain is an enormous problem. As an unmet medical need, pain causes suffering and comes with a multi-billion dollar societal cost. Current treatments are problematic because they cause intolerable side effects, diminish quality of life and do not sufficiently quell pain.
The most successful pharmacological approaches for the treatment of chronic pain rely on certain “pathways”: circuits involving opioid, adrenergic, and calcium channels.
For the past decade, scientists have tried to take advantage of these known pathways – the series of interactions between molecular-level components that lead to pain. While adenosine had shown potential for pain-killing in humans, researchers had not yet successfully leveraged this particular pain pathway because the targeted receptors engaged many side effects.
A Key to Pain Relief
In this research, Salvemini and colleagues have demonstrated that activation of the A3 adenosine receptor subtype is key in mediating the pain relieving effects of adenosine.
“It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain,” Salvemini said. “Our findings suggest that this goal may be achieved by focusing future work on the A3AR pathway, in particular, as its activation provides robust pain reduction across several types of pain.”
The Latest on: Pain relief
via Google News
The Latest on: Pain relief
- How a Naperville hospital uses virtual reality to ease pain -- and cure boredomon September 8, 2019 at 1:56 pm
"I got to relieve some of that post-treatment stress." As part of grant specifications, Bobo said, Edward is keeping stats on patients' perception of pain before and after a virtual experience, their ...
- Dechra to launch first-of-its-kind livestock pain relief product in boost for animal welfareon September 8, 2019 at 9:51 am
A Chesire-based pharmaceutical company is set to launch a pain relief medication for piglets, lambs and calves that promises to significantly improve welfare for these animals. Dechra Pharmaceuticals, ...
- Rob Gronkowski Talks CBD Partnership With Abacus Health: 'For The First Time In More Than A Decade, I'm Pain-Free'on September 8, 2019 at 8:10 am
"I was in near-constant pain and needed to make a change," Gronkowski told Benzinga. His father introduced him to CBDMEDIC products as he searched for more natural recovery methods. The NFL great felt ...
- UW study: Patients coming off opioids for pain 3 times more likely to die from overdoseon September 8, 2019 at 7:52 am
Researchers concluded that discontinuing chronic opioid therapy led to increased risk of death during the study, and recommend other forms of pain management and treatment of opioid-use disorder ...
- Walk aims to raise awareness of complex regional pain syndromeon September 7, 2019 at 7:46 pm
... early on versus cycling through months of medications that don’t work can be the difference between treatment that reduces long-term pain instead of treatment that eliminates it, Rubin said.
- CBD is popular for pain relief, but can Mom be convinced it'll help her?on September 7, 2019 at 5:07 am
Doug Bergren grows hemp. For a long time, his mother wasn't especially proud of that. Bergren, whose two hemp fields in Lorane currently are in bloom, said he obtained black sheep status with his ...
- Aleve® Demonstrates More Pain Relief Than a Commonly Prescribed Opioid After Wisdom Tooth Extraction, Studies Showon September 6, 2019 at 1:05 pm
Bayer Consumer Health Announces Data From Two Single-Dose Studies at Annual ADA Meeting WHIPPANY, N.J., Sept. 6, 2019 /PRNewswire/ -- Bayer today announced data that showed Aleve ® (naproxen ...
- Pain relief is demanded largely in today's world. We shouldn't aim only to feel better | Opinionon September 6, 2019 at 3:03 am
Peter Rosenberger hosts "hope for the caregiver" each week on Sirius XM’s Family Talk and American Family Radio. When it comes to people seeking pain relief, Jerry Seinfeld captured the trend wrapping ...
- Omron Healthcare Introduces Total Power + Heat TENS Device, Latest Addition to its Drug-Free Pain Relief Product Lineon September 4, 2019 at 5:08 pm
LAKE FOREST, Ill., Sept. 4, 2019 /PRNewswire/ -- Omron Healthcare, Inc., a global leader in personal heart health and wellness technology, today introduced Total Power + Heat as the latest ...
- Study Finds Cannabis Flower is Best Method for Pain Reliefon September 1, 2019 at 5:03 pm
Here's why you should consider smoking flower for pain relief. This video, "Study Finds Cannabis Flower is Best Method for Pain Relief", first appeared on nowthisnews.com.
via Bing News